ARTIMPLANT AB ANNUAL ACCOUNTS JAN 1 – DEC 31, 2005

• Net revenue increased by more than 70% and amounted 8,2 MSEK (4,8) • Net profit of -36,2 MSEK (-42,4) • Earnings per share of -0,73 SEK (-1,12 SEK) • Four new development and license agreements signed with Small Bone Innovations during the fourth quarter • Artelon® Surgical Suture received CE-mark and clearance for marketing in the USA • Artelon® implant for rotator cuff reinforcement received CE-mark • Distribution agreement for Artelon® Surgical Suture signed with ArthroCare Corporation • Six out of the seven goals communicated in share issue prospectus in May 2005 were fulfilled Events after the period • Artelon® implant for rotator cuff reinforcement received clearance for marketing in the USA • Artimplant established a small representation office in the US, Artimplant USA, Inc. Upcoming information events Interim report Jan-Mar 2006…………... May 3, 2006 Interim report Jan-Jun 2006……….. August 8, 2006 Interim report Jan-Sep 2006… …. November 9, 2006 Financial reports are available at www.artimplant.com simultaneously as distributed to the media. For information regarding business model, technology and products see Artimplant’s annual report 2004, which is available at the Company’s website. Annual general meeting The annual general meeting of shareholders will be held at 4 p.m. on May 3, 2006 at the Company headquarters. Registration will begin at 3:30 p.m. Shareholders who intend to participate must notify the Company no later than April 25, 2005, in one of the following ways: • Send an e-mail to agm2006@artimplant.se • Send a fax to +46 31 746 56 60 • Call +46 31 746 56 00 • Write to Artimplant AB, AGM, Hulda Mellgrens gata 5, 421 32 Västra Frölunda, Sweden. Please include name, personal id. number or company id. number, address, telephone number and the number of shares in the share register as per April 21, 2005. To vote at the annual general meeting, a shareholder must be part of the share register maintained by VPC AB no later than April 21, 2005. Shareholders who have shares registered through a bank or brokerage, must temporarily register their shares in their own name to take part in the meeting. This should be done well in advance of the date specified above. The annual report will be published on the Company’s web site no later than April 14, 2006, and will also be available at the Company headquarters. A copy of the annual report can be ordered by writing to the above address.

About Us

Artimplant is a research- and development company, active within bio-materials.

Subscribe

Documents & Links